Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT01995435 Completed - Eye Strain, Clinical Trials

Refraction Determination Analysis

Start date: February 2015
Phase: N/A
Study type: Interventional

Correlating the accuracy of a refraction done over telemedicine to that of a standard refraction, with a study hypothesis that the results will be equivalent.

NCT ID: NCT01988415 Completed - Myopia Clinical Trials

New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction for Myopia

Start date: November 2013
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to demonstrate that treatments generated by an investigational algorithm reduces spherical aberration compared to currently available iDesign treatments.

NCT ID: NCT01977807 Recruiting - Myopia Clinical Trials

A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIK

Start date: August 2014
Phase: Phase 4
Study type: Interventional

This clinical study has been planned to evaluate the safety and effectiveness of common treatment algorithms using 500 Hz laser repetition rate.

NCT ID: NCT01968486 Completed - Clinical trials for Myopia, Degenerative

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Start date: June 2012
Phase: Phase 1
Study type: Interventional

To demonstrate the efficacy of ranibizumab in combination with reduced-fluence verteporfin photodynamic therapy (RF-PDT) in patients with subfoveal choroidal neovascularization secondary to pathologic myopia (PM).

NCT ID: NCT01966770 Completed - Myopia Clinical Trials

Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses

Start date: October 2013
Phase: N/A
Study type: Interventional

The aim of this fitting study is to evaluate the clinical performance of different hydrogel and silicone hydrogel contact lenses.

NCT ID: NCT01965262 Completed - Myopia Clinical Trials

A Clinical Assessment of the Hemacopolymer Daily Disposable Limbal Ring Soft Contact Lens

Start date: April 2014
Phase: N/A
Study type: Interventional

This purpose of this study is to compare the clinical performance and subjective acceptance of two different daily disposable limbal ring lenses.

NCT ID: NCT01952665 Completed - Myopia Clinical Trials

A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear

Start date: October 2013
Phase: N/A
Study type: Interventional

A Multi-Center Study Comparing the Clinical Performance of Two Silicone Hydrogel Lenses Over 1 Month of Daily Wear

NCT ID: NCT01942057 Completed - Myopia Clinical Trials

Myopia Prevalence in Canadian School Children - a Pilot Study

Falcon
Start date: December 2013
Phase: N/A
Study type: Observational

The goal of this study is to determine the prevalence of nearsightedness in Canadian school children living in the Waterloo Region.

NCT ID: NCT01923675 Withdrawn - Myopia Clinical Trials

Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation

Start date: November 2013
Phase: N/A
Study type: Interventional

1. To determine the effect of spectacles with a red blocking filter on myopia progression in children. 2. To determine the effect of spectacles with a holographic diffuser that spreads incident light rays over an angle of 0.5 degrees on myopia progression in children 3. To determine the combined effects of spectacles with a red blocking filter and a diffuser that spreads incident light over an angle of 0.5 degrees on myopia progression in children.

NCT ID: NCT01922102 Completed - Clinical trials for Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Brilliance
Start date: September 11, 2013
Phase: Phase 3
Study type: Interventional

This study was designed to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab given as intravitreal injection in comparison to verteporfin PDT in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia (PM)